| - Industry | - Sector | - CEO | SSE Exchange | CNE100007093 ISIN |
| China Country | 3,734 Employees | 1 Jun 2026 Last Dividend | - Last Split | - IPO Date |
Shandong Weigao Blood Purification Products Co. Ltd. is a prominent medical technology company that specializes in blood purification solutions. Founded in 2004 and located in Weihai, Shandong Province, the company has established itself as a leader in the domestic industry, boasting independent core technologies in blood purification. The firm is dedicated to the research, development, production, and sales of a comprehensive range of products tailored for hemodialysis and peritoneal dialysis. Through relentless investment in R&D and strategic partnerships with esteemed international firms such as Terumo and NIKKISO, Shandong Weigao has developed a vertically integrated supply chain that effectively manages all aspects of blood purification treatments. The company's efforts are significantly directed toward supporting hospitals and healthcare professionals in the management of kidney diseases, enhancing the quality of life for patients both in China and internationally. Its steadfast commitment to quality and innovation solidifies its position as a fundamental player in the medical devices and health technology market.